VTE in Maternal Mortality: ThrombUS+ Horizon Europe Project and Elvira Grandone
“Maternal death during pregnancy, childbirth, or the postpartum period remains a major tragedy for families and communities. Although less than 1% of global maternal deaths occur in high-income countries, it is estimated that approximately 50% of these deaths are potentially preventable.
In line with the Sustainable Development Goals (2016–2030), European countries are also called to action to eliminate avoidable maternal and neonatal deaths. A critical first step is the improvement of data monitoring and reporting, ensuring that no maternal, fetal, or neonatal death goes unnoticed.
Recent data from the Italian Obstetric Surveillance System (ItOSS) revealed significant geographic disparities in maternal mortality across Italy, with higher rates in Southern regions (10.5 per 100,000 live births) compared to the North (7.7) and Center (5.9).
Among maternal deaths occurring within 42 days postpartum, direct obstetric causes accounted for 55.1%, with obstetric hemorrhage being the leading cause (37.1%), followed by sepsis (13.9%), hypertensive disorders (13.4%), and notably, venous thromboembolism (VTE) at 11.9%.
These findings highlight the urgent need for enhanced prevention, early recognition, and management of VTE, a still under-recognized but significant contributor to maternal mortality in Italy.
Data from ItOSS – Italian Obstetric Surveillance System
Data from Elvira Grandone, Ospedale Casa Sollievo della Sofferenza”
Stay informed with Hemostasis Today.
-
Sep 18, 2025, 06:50Fetal Hereditary TTP Featured in NEJM – Senior Author Nishant Rajendra Tiwari
-
Sep 17, 2025, 10:54Mitapivat Boosts ATP in Red Cells: Dr. William Aird on New Hope for Hemolytic Disorder
-
Sep 17, 2025, 08:16Superficial Vein Thrombosis Management: John Fanikos Shares Latest Review
-
Sep 17, 2025, 07:00Maha Othman - ''BIC 2025 is Without a Doubt a Remarkable Scientific Event — and I’m Excited for What Lies Ahead!''
-
Sep 16, 2025, 11:17Glenn Pierce: WHO Issues a Biannual Essential Medicines List
-
Sep 18, 2025, 07:00Rishabh Singh on NEJM Letter: FVIII Aurora Mutation Shows Increased Activity and Reduced APC Response
-
Sep 18, 2025, 02:25Flora Peyvandi Highlights 'Inflammatory Memory of Stem Cells' – New Insights for Hematologic Diseases
-
Sep 17, 2025, 16:32Endovascular Today: Dr. Eric Secemsky Analyzes Impact of Paclitaxel Pause on Peripheral Artery Disease Care
-
Sep 17, 2025, 16:28Haemnet Showcases Research on Severe Haemophilia A Patients Adapting to Emicizumab Therapy
-
Sep 17, 2025, 16:19Todd Villines: Coronary Artery Disease - A BIG Movement to Change
-
Sep 16, 2025, 14:59A New Era in Antiplatelet Therapy for CABG?
-
Sep 16, 2025, 07:44Artificial Blood Breakthrough in Japan: Long Shelf Life, No Type Matching, and a Purple Future
-
Sep 16, 2025, 02:44Wolfgang Miesbach Highlights First Inhibitor Case After Hemophilia A Gene Therapy (Giroctocogene Fitelparvovec)
-
Sep 12, 2025, 15:21Christian Schäfer: INR Self-Management Has Officially Been Given Class IA Status in the ESC Guidelines
-
Sep 9, 2025, 20:15Linking a Single Dominant Antibody to HIT: A Novel Study Led by Ishac Nazy, Donald Arnold, and John G. Kelton
-
Sep 18, 2025, 06:34'A New Era in Mechanical Thrombectomy?' – Sripal Bangalore Highlights SYMPHONY-PE IDE Study
-
Sep 17, 2025, 10:49Living with Glanzmann Thrombasthenia․ Eliza VanZweden’s Story of Resilience and Advocacy
-
Sep 17, 2025, 10:22Abdul Mannan: Turning Medical Podcasts into Active Learning with Structured Tools
-
Sep 17, 2025, 09:43Global Blood Supply Under Threat: David McIntosh Calls for Action to Support Transfusion Services
-
Sep 17, 2025, 09:08Coronary Arteries, Pericardial Cavity, and the Hidden Danger of Cardiac Tamponade During PCI-By Ahmed Ata